Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective

Research output: Contribution to journalArticleAcademicpeer-review

5 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Proposal for individualized dosing of eculizumab in atypical haemolytic uraemic syndrome: patient friendly and cost-effective'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science